Sourced from:Direct from Manufacturer
Quick Summary
Herlapsa 250mg Tablet
Last updated on 26 Sep 2026 | 08:44 AM (IST)
₹6111
MRP: ₹8057
(You Save ₹1946)
30 TABLET(s) IN A BOTTLE
Sourced from:Direct from Manufacturer
24% OFF
₹6111
MRP: ₹8,057.00
Inclusive of all taxes
24% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Lapakast 250mg Tablet
APRAZER HEALTHC...
₹ 92.43/tablet
54% cheaper
Lapibuzz 250mg Tablet
JASGUR LIFE SCI...
₹ 100.60/tablet
50% cheaper
Lapagis 250mg Tablet
AEGIS PHARMACEU...
₹ 109.27/tablet
46% cheaper
Lapalieva 250mg Tablet
Allieva Pharma ...
₹ 109.43/tablet
46% cheaper
Better Service Satisfied Customers
Introduction
Herlapsa 250mg Tablet contains Lapatinib as its active ingredient. It is used in the treatment of HER2-positive breast cancer, either alone or in combination with other anti-cancer medicines. The drug works by blocking the activity of the human epidermal growth factor receptor-2 (HER2), slowing down or stopping the growth of cancer cells.
Doctors decide the Herlapsa 250mg dosage for breast cancer based on the patient’s condition, response to treatment, and any other medicines being used. It is usually taken once daily on an empty stomach or as advised by a medical professional. Regular monitoring of liver function, heart activity, and blood counts is recommended during treatment.
The Herlapsa 250mg composition includes Lapatinib Ditosylate Monohydrate, which helps target cancer cells that produce excess HER2 protein. This targeted action makes it especially effective in managing advanced and metastatic breast cancer.
Patients often compare Herlapsa 250mg vs Tykerb, as both contain the same active ingredient (Lapatinib) and work in a similar way. However, pricing and manufacturer may differ, leading some patients to prefer one over the other. Many Herlapsa 250mg reviews highlight its effectiveness in controlling disease progression when used as prescribed and monitored carefully.
For affordability and accessibility, patients can check the Herlapsa 250mg price in India through verified pharmacies. The cost may vary depending on region, pharmacy discounts, and whether it is purchased offline or online. You can also buy Herlapsa 250mg online or make a Herlapsa 250mg tablet online purchase from authorized medical platforms that require a valid prescription. This ensures product authenticity and safe delivery.
In case of non-availability or based on medical advice, your oncologist may recommend a Herlapsa 250mg substitute in India with a similar composition and therapeutic action. Substitution should always be done under the supervision of a healthcare provider, as treatment response and tolerability may vary.
The Herlapsa 250mg manufacturer follows strict quality standards and ensures the medicine meets all safety and efficacy benchmarks before distribution. It is widely prescribed by oncologists across India for HER2-positive breast cancer.
Uses
herlapsa 250mg uses are
- Treats advanced or HER2 Positive metastatic breast cancer.
How Herlapsa 250mg Tablet works
Lapatinib in Herlapsa 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) from signalling, which are produced by breast cancer cells. It kills cancer cells and slows down their growth.
Interaction of Herlapsa 250mg Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Herlapsa 250mg Tablet Injection and cause undesirable side effects.
Storage conditions
- Store below 30°C and away from light.
How to take Herlapsa 250mg Tablet
Take Herlapsa 250mg Tablet exactly as prescribed by your doctor. Take this medicine at least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them.
Safety Advice for Herlapsa 250mg Tablet
Breast Feeding
Herlapsa 250mg Tablet is unsafe during breastfeeding as this medication tends to pass into the breast milk and affect the baby.
Alcohol
Avoid drinking alcohol while taking Herlapsa 250mg Tablet as it may cause dizziness.
Liver
Herlapsa 250mg Tablet should be used with caution in patients with severe liver disease. Consult your physician for advice.
Lungs
Talk to your doctor if you have any lung conditions before starting treatment with Herlapsa 250mg Tablet.
Driving
Herlapsa 250mg Tablet may affect your ability to drive or perform activities that require focus. Exercise caution while driving or using machines.
Pregnancy
It is not safe to consume Herlapsa 250mg Tablet while you are pregnant. Consult your doctor and use a reliable contraception method to avoid becoming pregnant during this treatment.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Herlapsa 250mg tablet side effects
Serious
- Diarrhea
- Severe allergic reactions
- Skin rash
- Heart problems
Common
- Loss of appetite
- Nausea, vomiting
- Tiredness, weakness
- Indigestion
- Constipation
- Sore mouth or mouth ulcers
- Stomach pain
- Trouble sleeping
- Back pain
- Pain in the hands and feet
- Joint or back pain
- Cough, breathlessness
- Headache
- Nose bleed
- Hot flush
- Unusual hair loss
- Dry skin and itching
Expert Tips
-
Herlapsa 250mg Tablet can cause severe diarrhea; drink plenty of water during treatment.
-
Follow a well-balanced diet to support your health while on medication.
-
Avoid grapefruit juice during treatment, as it can interfere with how the medicine works.
-
This medicine makes the skin more sensitive to sunlight, increasing the risk of rashes.
-
Limit sun exposure and always apply a sunscreen with good SPF before going outside.
-
Wash your skin with a soap-free cleanser to reduce irritation.
FAQs about Herlapsa 250mg Tablet
Q1.
What is Herlapsa 250mg Tablet used for?
Herlapsa 250mg Tablet is used to treat advanced or HER2 Positive metastatic breast cancer.
Q2.
What is the most common side effect of Herlapsa 250mg Tablet?
The most common side effect of Herlapsa 250mg Tablet is Diarrhea. To prevent dehydration, consume lots of liquids, such as water or juice. If it is serious, consult your doctor right away.
Q3.
What is the action of Herlapsa 250mg Tablet in treating breast cancer?
Herlapsa 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and epidermal growth factor receptors (EGFRs) from signaling, which breast cancer cells produce. It kills cancer cells and slows down their growth.
Q4.
Is it safe to take Herlapsa 250mg Tablet while drinking juice?
No. Drinking grapefruit juice while taking Herlapsa 250mg Tablet can cause harmful interaction. Take this medicine with water only.
Q5.
Can a pregnant woman take Herlapsa 250mg Tablet?
No, Herlapsa 250mg Tablet is unsafe during pregnancy as it may harm the unborn baby. Therefore, it is advisable to tell your healthcare provider if you are pregnant or planning to have a baby before taking this medicine.
Q6.
Is Herlapsa 250mg Tablet safe for breastfeeding women?
Herlapsa 250mg Tablet is unsafe during breastfeeding as this medication passes into the breastmilk and affects the baby. It is not to be taken without the doctor's consent.
Fact Box of Herlapsa 250mg Tablet
|
Molecule name
| Lapatinib |
|
Therapeutic class | Antineoplastic agent |
|
Pharmacological class | Kinase inhibitor |
|
Indications |
Treats advanced or HER2-positive metastatic breast cancer. |
References
1. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
2. KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.
3. Novartis Europharm Limited, Electronic medicines compendium (emc), [ Revised on March 2022] [ Accessed on 19th August 2022], https://www.medicines.org.uk/emc/files/pil.6292.pdf
4. GlaxoSmithKline, US Food & Drug Administration, [ Accessed on 19th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022059s007lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Sakshi Anil More
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:44 AM (IST)
Want to know more?
Read Our Editorial Policy
